The Seed Investor
Early Stage Investing
Join our Newsletter  Hand-picked cannabis stocks, news & alerts straight to your inbox (100% FREE!)
  •  
  • Cannabis News
  • Marijuana Industry
  • Marijuana Investing
  • Psychedelics
  • Featured Companies
  • TSI Exclusive
  • About
    • Overview
    • Disclaimer
    • Advertise
    • Privacy Policy

Trending Now

  • Compass Pathways Files For NASDAQ Listing: Psychedelics Game-Changer
  • MindMed And Eleusis Lead The Way In Psychedelics Micro-Dosing Research
  • Why Psychedelics Micro-Dosing Applications Have The Inside Track On Commercialization
  • Cannabis Sales Soar 48% In 2019, 2020 Looking Even Stronger
  • Is CBD ‘Harmful’ to Our Liver? No.
  • Industry Leaders Leading Turnaround in Marijuana Stocks?
Psychedelic Stocks
Exploring the companies and themes that make up this emerging and exciting new sector

COMPASS Pathways to fund study of COMP360 psilocybin in autistic adults

2022-05-09 PSW Editor

Compass Pathways announces the first-ever study of psilocybin therapy on autistic adults, using COMP360.

New York Lawmakers Discuss Competing Psychedelics Reform Bills Ahead Of Key Deadline

2022-05-06 Noah Daly

With just a month left before the end of New York’s legislative session, lawmakers sponsoring differing psychedelics reform legislation recently participated in a discussion on the path forward for psilocybin in the Empire State.

PharmaTher Announces Grant of U.S. Patent on Formulation and Production Process of Ketamine and Ketamine Analogs

2022-05-05 PSW Editor

Pharmather announces receiving a patent from the USPTO for its "ketamine flow synthesis". Pharmather has exclusive worldwide development and commercial rights to this IP.

MYDECINE INNOVATIONS GROUP ANNOUNCES CLOSING UNDER SHARE SUBSCRIPTION AGREEMENT

2022-05-04 PSW Editor

Mydecine announces raising $1,693,434.60 in addition to gross proceeds of $333,333.35 announced on March 22, 2022.

Wesana Health Reports Q4 2021 Financial Results and Provides Subsequent Period Highlights

2022-05-04 PSW Editor

Wesana reports its Q4 2021 financial results and announces closing of a financing.

Awakn Life Sciences Reports Fiscal Fourth Quarter and Fiscal Year January 31, 2022, Results

2022-05-02 PSW Editor

Awakn Life Sciences reports fourth quarter and full-year results for its fiscal year ending January 31, 2022. Annual revenues of CAD$236,037.

Optimi Health Opens Canada’s Largest GMP-Grade Licensed Psilocybin Cultivation Facility

2022-04-29 PSW Editor

Optimi Health announces the opening of Canada's largest GMP-grade psilocybin cultivation operating, including a 10,000 square foot production facility.

Incannex Completes Loyalty Option Program to Raise A$23.6M; Current Cash at Bank is Approximately A$40.0M

2022-04-29 PSW Editor

Incannex Healthcare announces a "shareholder loyalty option" to raise A$23.6 million (US$16.5 million). For every two shares purchased, investors will receive a "piggyback option".

Is The Psychedelic Drug Industry Entering A New Phase?

2022-04-28 Jeff Nielson

Several major new deals in the psychedelics industry already in 2022 suggest that the industry could be moving on to its next phase of evolution.

TRYP THERAPEUTICS DOSES FIRST PATIENT IN PHASE II PSILOCYBIN-ASSISTED THERAPY CLINICAL TRIAL

2022-04-28 PSW Editor

Tryp Therapeutics announces initial patient enrollment in its Phase II clinical trial of a psilocybin-based compound (TRP-8802) for Binge Eating Disorder.

Field Trip Health Ltd. Announces Intention to Separate the Field Trip Discovery and Field Trip Health Divisions Into Two Independent Public Companies

2022-04-28 PSW Editor

Field Trip announces its corporate decision to separate Field Trip Health and Field Trip Discovery into separate companies.

Is Minera Alamos Revolutionizing Gold Mining For The 21st Century?

2022-04-27 Jeff Nielson

Minera Alamos' "new" model for successful gold mining in the 21st century has a very retro flair to it.

  • Previous
  • 1
  • ...
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • ...
  • 74
  • Next
Join our Newsletter
 Hand-picked cannabis stocks, news & alerts straight to your inbox (100% FREE!)

The Seed Investor Exclusive

Compass Pathways Files For NASDAQ Listing: Psychedelics Game-Changer

Compass Pathways Files For NASDAQ Listing: Psychedelics Game-Changer

2020-08-31
A major IPO can be expected to attract a lot of new attention (and capital) to the psychedelic drug industry.

The Psychedelics Revolution: From ‘War on Drugs’ To Funding Psychedelic Drug Research

Eleusis Looks For Alzheimer’s Breakthrough With Micro-Dosed LSD

What Does Field Trip Psychedelics Offer Investors?

Canadians More Receptive To Use Of Psilocybin For The Terminally Ill: New Poll

Psychedelic Stocks
NEWS
INDUSTRY
INVESTING
COMPANIES
EXCLUSIVE

Newsletter

Get The Seed Investor straight to your email.

Copyright © 2016-2023, The Seed Investor | About | Contact | Advertise | Privacy Policy | Disclaimer
Powered by StructureCMS
The Seed Investor